{"url":"https://lda.senate.gov/api/v1/filings/dcefddf8-60b1-4e6c-973c-bd5ae32aff3f/","filing_uuid":"dcefddf8-60b1-4e6c-973c-bd5ae32aff3f","filing_type":"RR","filing_type_display":"Registration","filing_year":2026,"filing_period":"first_quarter","filing_period_display":"1st Quarter (Jan 1 - Mar 31)","filing_document_url":"https://lda.senate.gov/filings/public/filing/dcefddf8-60b1-4e6c-973c-bd5ae32aff3f/print/","filing_document_content_type":"text/html","income":null,"expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"Bryan Shuy","dt_posted":"2026-02-27T16:15:14-05:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"1001 Pennsylvania Ave, NW","registrant_address_2":"13th Floor North","registrant_different_address":null,"registrant_city":"Washington","registrant_state":"DC","registrant_zip":"20004","registrant":{"id":401004840,"url":"https://lda.senate.gov/api/v1/registrants/401004840/","house_registrant_id":null,"name":"THE CONAFAY GROUP, LLC","description":"Life Sciences Consulting Firm","address_1":"1001 Pennsylvania Ave, NW","address_2":"13th Floor North","address_3":null,"address_4":null,"city":"Washington","state":"DC","state_display":"District of Columbia","zip":"20004","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"ERICA WOODWARD","contact_telephone":"+1 859-229-7237","dt_updated":"2026-01-30T10:00:55.918324-05:00"},"client":{"id":71503,"url":"https://lda.senate.gov/api/v1/clients/71503/","client_id":71503,"name":"BRIGHT PATH LABORATORIES, INC.","general_description":"Pharmaceutical company","client_government_entity":null,"client_self_select":false,"state":"AZ","state_display":"Arizona","country":"US","country_display":"United States of America","ppb_state":"AZ","ppb_state_display":"Arizona","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2026-02-02"},"lobbying_activities":[{"general_issue_code":"MED","general_issue_code_display":"Medical/Disease Research/Clinical Labs","description":"Policies that promote domestic pharmaceutical manufacturing.","foreign_entity_issues":null,"lobbyists":[{"lobbyist":{"id":107429,"prefix":null,"prefix_display":null,"first_name":"JOSH","nickname":null,"middle_name":null,"last_name":"NARROW","suffix":null,"suffix_display":null},"covered_position":"Intern to Senator Casey","new":true},{"lobbyist":{"id":143511,"prefix":null,"prefix_display":null,"first_name":"BRYAN","nickname":null,"middle_name":null,"last_name":"SHUY","suffix":null,"suffix_display":null},"covered_position":"Chief of Staff Rep. Harris; Asst. to Rep. Harris, House Cmte on Approps; Dep. Asst. Sec and Chief of Staff HHS/Asst.Secretary for Preparedness and Response (ASPR)","new":true}],"government_entities":[]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]}